Equities

PhoenixBio Co Ltd

6190:TYO

PhoenixBio Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)460.00
  • Today's Change0.00 / 0.00%
  • Shares traded9.70k
  • 1 Year change-18.29%
  • Beta0.7418
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue1,7152,1241,325
OPERATING EXPENSES
Cost of revenue total520568597
Selling, general and admin. expenses, total969835664
Depreciation/amortization8.367.9412
Unusual expense(income)1.030.66265
Other operating expenses, total0.000.00--
Total operating expense1,7051,6161,757
Operating income10508(433)
Other, net121317
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes60511(393)
Provision for income taxes3317(5.03)
Net income after taxes26493(388)
Minority interest------
Net income before extra. Items26493(388)
Total extraordinary items------
Net income26493(388)
Inc.avail. to common excl. extra. Items26493(388)
Inc.avail. to common incl. extra. Items26493(388)
EPS RECONCILIATION
Basic/primary weighted average shares3.783.403.30
Basic/primary eps excl. extra items6.98145(117)
Basic/primary eps incl. extra items6.98145(117)
Dilution adjustment------
Diluted weighted average shares3.785.073.30
Diluted eps excl. extra items6.9897(117)
Diluted eps incl. extra items6.9897(117)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue000
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental2.933.070.95
SUPPLEMENTAL INCOME
Depreciation, supplemental252486
Total special items1.030.66265
NORMALISED INCOME
Normalized income before taxes61511(128)
Effect of special items on income taxes0.570.0293
Income tax excluding impact of special items341788
Normalized income after tax27494(216)
Normalized income avail. to common27494(216)
Basic normalized EPS7.09145(65)
Diluted normalized EPS7.0997(65)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.